|
INO80D expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.56809999827001E-08 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.37440000000677E-06 |
| Normal-vs-Stage2 |
2.24489999999244E-05 |
| Normal-vs-Stage3 |
4.61939999585326E-08 |
| Normal-vs-Stage4 |
7.55930000040372E-07 |
| Stage1-vs-Stage2 |
1.965790E-01 |
| Stage1-vs-Stage3 |
5.633600E-02 |
| Stage1-vs-Stage4 |
6.791600E-02 |
| Stage2-vs-Stage3 |
9.310400E-01 |
| Stage2-vs-Stage4 |
7.018600E-01 |
| Stage3-vs-Stage4 |
7.066800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.80910000208345E-08 |
| Normal-vs-AfricanAmerican |
9.662700E-03 |
| Normal-vs-Asian |
1.379440E-03 |
| Caucasian-vs-AfricanAmerican |
5.116000E-01 |
| Caucasian-vs-Asian |
1.977420E-01 |
| AfricanAmerican-vs-Asian |
7.927400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.87656999999231E-05 |
| Normal-vs-Female |
4.6829999988951E-08 |
| Male-vs-Female |
2.624600E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.8808999999973E-05 |
| Normal-vs-Age(41-60Yrs) |
4.28650000050546E-07 |
| Normal-vs-Age(61-80Yrs) |
2.70459999951456E-07 |
| Normal-vs-Age(81-100Yrs) |
1.53353999999828E-05 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.082200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.991600E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.638470E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.031400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.814200E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.810200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.239800E-02 |
| Classical-VS-Follicular |
1.651620E-02 |
| Classical-VS-Other |
6.847200E-01 |
| Classical-VS-Normal |
1.62178999999485E-05 |
| Tall-VS-Follicular |
6.365000E-01 |
| Tall-VS-Other |
4.250200E-01 |
| Tall-VS-Normal |
4.59760000004472E-06 |
| Follicular-VS-Other |
6.681000E-01 |
| Follicular-VS-Normal |
7.92929999993142E-07 |
| Other-VS-Normal |
5.484200E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.01080000036724E-07 |
| Normal-vs-N1 |
2.174200E-04 |
| N0-vs-N1 |
6.301800E-01 |
|
|
